Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)

Joleen M. Hubbard, Michelle R. Mahoney, William S. Loui, Lewis R. Roberts, Thomas C. Smyrk, Zoran Gatalica, Mitesh Borad, Shaji Kumar, Steven R. Alberts

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)'. Together they form a unique fingerprint.

Medicine & Life Sciences